PSORIASIS
CURE & TREATMENTS IN AYURVEDA
About Psoriasis:
Psoriasis is a chronic,
autoimmune disease that appears on the skin. It occurs
when the immune system sends out faulty signals that
speed up the growth cycle of skin cells. Psoriasis is
not contagious.
There are five types of
psoriasis: plaque, guttate, inverse, pustular and
erythrodermic. The most common form, plaque psoriasis,
appears as raised, red patches or lesions covered with
a silvery white build-up of dead skin cells, called
scale. Psoriasis can occur on any part of the body and
is associated with other serious health conditions,
such as diabetes, heart disease and depression
Type of psoriasis
Psoriasis appears in a
variety of forms with distinct characteristics.
Typically, an individual has only one type of
psoriasis at a time. Generally, one type of psoriasis
will clear and another form of psoriasis will appear
in response to a
trigger.
Plaque Psoriasis -
(psoriasis vulgaris)


Plaque psoriasis
(psoriasis vulgaris) is the most prevalent form of the
disease. About 80 percent of those who have psoriasis
have this type. It is characterized by raised,
inflamed, red lesions covered by a silvery white
scale. It is typically found on the elbows, knees,
scalp and lower back.
Guttate Psoriasis -

Guttate [GUH-tate]
psoriasis is a form of psoriasis that often starts in
childhood or young adulthood. The word guttate is from
the Latin word meaning "drop." This form of psoriasis
appears as small, red, individual spots on the skin.
Guttate lesions usually appear on the trunk and limbs.
These spots are not usually as thick as plaque
lesions.
Guttate psoriasis often
comes on quite suddenly. A variety of conditions can
bring on an attack of guttate psoriasis, including
upper respiratory infections, streptococcal throat
infections (strep throat), tonsillitis, stress, injury
to the skin and the administration of certain drugs
including antimalarials and beta-blockers.
Inverse Psoriasis -

Inverse
psoriasis is found in the armpits, groin, under the
breasts, and in other skin folds around the genitals
and the buttocks. This type of psoriasis appears as
bright-red lesions that are smooth and shiny. Inverse
psoriasis is subject to irritation from rubbing and
sweating because of its location in skin folds and
tender areas. It can be more troublesome in overweight
people and those with deep skin folds.
Pustular Psoriasis -

Primarily seen in adults, pustular psoriasis is
characterized by white blisters of noninfectious pus
(consisting of white blood cells) surrounded by red
skin. There are
three types of pustular psoriasis.
Pustular psoriasis may be localized to certain areas
of the body, such as the hands and feet, or covering
most of the body. It begins with the reddening of the
skin followed by formation of pustules and scaling.
Pustular psoriasis may be
triggered by internal medications, irritating topical
agents, overexposure to UV light, pregnancy, systemic
steroids, infections, stress and sudden withdrawal of
systemic medications or potent topical steroids.
Erythrodermic Psoriasis
-

Erythrodermic
[eh-REETH-ro-der-mik] psoriasis is a particularly
inflammatory form of psoriasis that affects most of
the body surface. It may occur in association with
von Zumbusch pustular psoriasis. It is
characterized by periodic, widespread, fiery redness
of the skin and the shedding of scales in sheets,
rather than smaller flakes. The reddening and shedding
of the skin are often accompanied by severe itching
and pain, heart rate increase, and fluctuating body
temperature.

Psoriasis of a Finger
Nail
People experiencing the
symptoms of erythrodermic psoriasis flare should go
see a doctor immediately. Erythrodermic psoriasis
causes protein and fluid loss that can lead to severe
illness. The condition may also bring on infection,
pneumonia and congestive heart failure. People with
severe cases of this condition often require
hospitalization.
Known triggers of
erythrodermic psoriasis include the abrupt withdrawal
of a systemic
psoriasis treatment including cortisone;
allergic reaction to a drug resulting in the
Koebner response; severe sunburns;
infection; and medications such as lithium,
anti-malarial drugs; and strong coal tar products.
Causes of psoriasis
No one knows exactly what
causes psoriasis. However, it is understood that the
immune system and genetics play major roles in its
development. Most researchers agree that the immune
system is somehow mistakenly triggered, which causes a
series of events, including acceleration of skin cell
growth. A normal skin cell matures and falls off the
body in 28 to 30 days. A skin cell in a patient with
psoriasis takes only 3 to 4 days to mature and instead
of falling off (shedding), the cells pile up on the
surface of the skin, forming psoriasis lesions.
Scientists believe that
at least 10 percent of the general population inherits
one or more of the genes that create a predisposition
to psoriasis. However, only 2 percent to 3 percent of
the population develops the disease. Researchers
believe that for a person to develop psoriasis, the
individual must have a combination of the genes that
cause psoriasis and be exposed to specific external
factors known as “triggers.”
Learn more about genetic
and immune system involvement in psoriasis and
psoriatic arthritis.
Psoriasis triggers
Psoriasis triggers are
not universal. What may cause one person’s psoriasis
to become active, may not affect another. Established
psoriasis triggers include:
Stress
Stress can cause
psoriasis to flare for the first time or aggravate
existing psoriasis. Relaxation
and stress reduction may help prevent stress
from impacting psoriasis.
Injury to skin
Psoriasis can appear in
areas of the skin that have been injured or
traumatized. This is called the Koebner [KEB-ner]
phenomenon. Vaccinations, sunburns and scratches can
all trigger a Koebner response. The Koebner response
can be treated if it is caught early enough.
Medications
Certain medications are
associated with triggering psoriasis, including:
Lithium: Used to treat
manic depression and other psychiatric disorders.
Lithium aggravates psoriasis in about half of those
with psoriasis who take it.
Antimalarials:
Quinacrine, chloroquine and hydroxychloroquine may
cause a flare of psoriasis, usually 2 to 3 weeks after
the drug is taken. Hydroxychloroquine has the lowest
incidence of side effects.
Inderal: This high blood
pressure medication worsens psoriasis in about 25
percent to 30 percent of patients with psoriasis who
take it. It is not known if all high blood pressure
(beta blocker) medications worsen psoriasis, but they
may have that potential.
Quinidine: This heart
medication has been reported to worsen some cases of
psoriasis.
Indomethacin: This is a
nonsteroidal anti-inflammatory drug used to treat
arthritis. It has worsened some cases of psoriasis.
Other anti-inflammatories usually can be substituted.
Indomethacin's negative effects are usually minimal
when it is taken properly. Its side effects are
usually outweighed by its benefits in psoriatic
arthritis.
Other triggers
Although scientifically
unproven, some people with psoriasis suspect that
allergies, diet and weather trigger their psoriasis.
Strep infection is known to trigger guttate psoriasis.
Prevalence
Psoriasis is one of the
most prevalent autoimmune diseases in the
U.S.
According to the
National Institutes of Health (NIH), as many as 7.5
million Americans—approximately 2.2 percent of the
population--have psoriasis.
125 million people
worldwide—2 to 3 percent of the total population—have
psoriasis.
Studies show that
between 10 and 30 percent of people with psoriasis
also develop psoriatic arthritis.
Psoriasis prevalence in
African Americans is 1.3 percent compared to 2.5
percent of Caucasians.1
Quality of life related
to Psoriasis
Psoriasis is not a
cosmetic problem. Nearly 60 percent of people with
psoriasis reported their disease to be a large problem
in their everyday life.
Nearly 40 percent with
psoriatic arthritis reported their disease to be a
large problem in everyday life.3
Patients with moderate
to severe psoriasis experienced a greater negative
impact on their quality of life.4
Psoriasis has a greater
impact on quality of life in women and younger
patients.4
Age of onset related to
Psoriasis
Psoriasis often appears
between the ages of 15 and 25, but can develop at any
age.
Psoriatic arthritis
usually develops between the ages of 30 and 50, but
can develop at any age.
Severity of psoriasis
The National Psoriasis
Foundation defines mild psoriasis as affecting less
than 3 percent of the body; 3 percent to 10 percent is
considered moderate; more than 10 percent is
considered severe. For most individuals, the palm of
the hand is about the same as 1 percent of the skin
surface. However, the severity of psoriasis is also
measured by how psoriasis affects a person's quality
of life.
Nearly one-quarter of
people with psoriasis have cases that are considered
moderate to severe.
Genetic aspects of
psoriasis
About one out of three
people with psoriasis report having a relative with
psoriasis.
If one parent has psoriasis, a child has about a 10
percent chance of having psoriasis. If both parents
have psoriasis, a child has approximately a 50 percent
chance of developing the disease.
Other health concerns associated with psoriasis
and psoriatic arthritis
Individuals with psoriasis are at an elevated risk to
develop other chronic and serious health conditions
also known as "comorbid diseases" or "comorbidities."
These include heart disease, inflammatory bowel
disease and diabetes. People with more severe cases of
psoriasis have an increased incidence of psoriatic
arthritis, cardiovascular disease, hypertension,
diabetes, cancer, depression, obesity, and other
immune-related conditions such as Crohn's disease1.
Cardiovascular risk
An October 2006 study confirmed the increased risk of
cardiovascular disease for psoriasis patients,
especially those with severe psoriasis in their 40s
and 50s. Psoriasis patients should examine their
modifiable risk factors—for example, quit smoking,
reduce stress and maintain a normal weight.
Depression
Psoriasis can cause considerable emotional distress
for patients, including decreased self-esteem, and an
increased incidence of mood disorders, such as
depression. One study estimates that approximately
one-fourth of psoriasis patients suffer from
depression. Learn more about the
risk for developing depression.
Cancer
A
number of studies have found an
increased risk of certain types of cancer in psoriasis patients, such as a form of skin cancer
known as squamous cell carcinoma and lymphoma. In some
instances, these cancers have been associated with
specific psoriasis treatments which suppress the
immune system. Patients should follow recommended
regular health screenings for cancer and avoid high
risk behaviors.
Resources
The National Psoriasis Foundation Medical Board urges
psoriasis patients to work with their doctors to
outline an appropriate preventative program based on
individual medical histories and known risk factors to
ensure they are continually monitoring for the
potential onset of any health issues related to
psoriasis.
Conception and pregnancy
In general, psoriasis
does not affect the male or female reproductive
systems. However, many psoriasis treatments require
special precautions before and during pregnancy. It is
important to consult with your doctor to verify your
psoriasis treatments are safe for pregnancy and
nursing.
How psoriasis changes
during pregnancy
Some women see an
improvement in the severity of their psoriasis during
pregnancy, while others report their psoriasis gets
worse. Changes in severity of psoriasis vary by
individual and from pregnancy to pregnancy.
Psoriatic arthritis and pregnancy
Although medications should be limited during
conception and pregnancy, this may be impossible for
those who have psoriatic
arthritis. Some pain medications can be used
safely during pregnancy. Talk with your doctor about
all over-the-counter and prescription medications you
take before conception, during pregnancy and while
nursing.
Genetic aspects of
psoriasis
Psoriasis is
believed to be a genetic disease, but it
does not follow a typical dominant or recessive
pattern of inheritance. No one can predict who will
get psoriasis as researchers do not completely
understand how psoriasis is passed from one generation
to another. The pattern of inheritance probably
involves multiple genes or combinations of many genes,
and the search is on to find those genes.
About one out of three
people with psoriasis report that a relative has or
had psoriasis. If one parent has psoriasis, a child
has about a 10 percent chance of having psoriasis. If
both parents have psoriasis, a child has approximately
a 50 percent chance of being diagnosed with the
disease.
Studies of identical
twins with psoriasis show that psoriasis is at least
partially genetic. But those same studies also
reinforce the complexity of psoriasis. In about
one-third of identical twin pairs where psoriasis is
present, only one twin has the disease, indicating
that environmental factors or “triggers”
play a role in who develops psoriasis. The theory that
psoriasis is triggered by a combination of genes and
external forces is called "multifactorial
inheritance." Once the genes responsible for psoriasis
are discovered, the inheritance pattern may be better
understood.
Discrimination
Many people with
psoriasis report facing discrimination in public
places such as swimming pools, hair salons and gyms
because others fear psoriasis is contagious.
Fortunately, there are federal laws designed to
protect you from discrimination. When it comes to
challenging discrimination, you are your own best
advocate.
Accessing health care
As with most chronic,
autoimmune diseases, psoriasis and psoriatic arthritis
require ongoing treatment. In order to best manage
your condition, it is important to see a doctor
regularly who specializes in treating psoriasis and/or
psoriatic arthritis.
Navigating the health
care system and applying for disability are not always
easy, so we've compiled this list of resources for you
to help you
access the care you need to get—and
stay—healthy with a chronic condition.
About psoriasis in children
Psoriasis is a genetic
skin disease associated with the immune system. The
immune system causes skin cells to reproduce too
quickly. A normal skin cell matures and falls off the
body’s surface in 28 to 30 days. However, skin
affected by psoriasis takes only three to four days to
mature and move to the surface. Instead of falling off
(shedding), the cells pile up and form lesions. The
skin also becomes very red due to increased blood
flow.
Who is affected?
The disease affects as
many as 7.5 million people in the U.S, about 2.6
percent of the population. Psoriasis occurs nearly
equally in men and women across all socioeconomic
groups. It occurs in all races, though Caucasians are
slightly more affected.
Ordinarily, people have
their first outbreak between the ages of 15 and 35,
but it can appear at any age. Approximately one-third
of those who get psoriasis are under 20 years old when
the disease first surfaces.
Every year, roughly
20,000 children under 10 years of age are diagnosed
with psoriasis. Sometimes it is misdiagnosed because
it is confused with other skin diseases. Symptoms
include pitting and discoloration of the nails, severe
scalp scaling, diaper dermatitis or plaques similar to
that of adult psoriasis on the trunk and extremities.
Psoriasis in infants is uncommon, but it does occur.
Only close observation can determine if an infant has
the disease.
Cause of Psoriasis
No one knows exactly what
causes psoriasis, but it has a genetic component. Most
researchers agree that the immune system is somehow
mistakenly triggered, which speeds up the growth cycle
of skin cells.
Researchers believe that
for a person to develop psoriasis, certain steps must
happen. The individual must receive a combination of
different genes that work together to cause psoriasis.
The individual must then be exposed to specific
factors that can trigger his or her particular
combination of genes to cause the disease. These
triggers are not yet fully understood or defined;
however, certain types of infection and stress have
been identified as potential triggers.
If one parent has the
disease, there is about a 10 percent chance of a child
contracting it. If both parents have psoriasis, the
chance increases to 50 percent. No one can predict who
will get psoriasis. Scientists now believe that at
least 10 percent of the general population inherits
one or more of the genes that create a predisposition
to psoriasis. However, only 2 to 3 percent of the
population develops the disease.
Triggers
Some young people report
the onset of psoriasis following an infection,
particularly strep throat. One-third to one-half of
all young people with psoriasis may experience a
flare-up two to six weeks after an earache, strep
throat, bronchitis, tonsillitis or a respiratory
infection.
Areas of skin that have
been injured or traumatized are occasionally the sites
of psoriasis, know as the “Koebner [keb-ner]
phenomenon.” However, not everyone who has psoriasis
develops it at the site of an injury.
The cause of psoriasis is not
known, but it is believed to have a
genetic component. Factors that may
aggravate psoriasis include
stress,
excessive alcohol consumption, and
smoking. There are many treatments available, but because of
its chronic recurrent nature psoriasis is a challenge
to treat.
Clinical classification
of Psoriasis
Psoriasis is a chronic relapsing
disease of the skin, which may be classified into
nonpustular and
pustular types as follows:
-
Nonpustular
psoriasis
-
Psoriasis vulgaris
(Chronic stationary psoriasis, Plaque-like
psoriasis)
-
Psoriatic erythroderma (Erythrodermic
psoriasis)
-
Pustular
psoriasis
-
Generalized pustular psoriasis (Pustular
psoriasis of von Zumbusch)
-
Pustulosis palmaris et plantaris
(Persistent palmoplantar pustulosis, Pustular
psoriasis of the Barber type, Pustular psoriasis
of the extremities)
-
Annular pustular psoriasis
-
Acrodermatitis
continua
-
Impetigo herpetiformis
Additional types of psoriasis
include
-
Drug-induced psoriasis
-
Inverse psoriasis
-
Napkin psoriasis
-
Seborrheic-like psoriasis
(content courtesy -
The National Psoriasis Foundation)
©
2009
National Psoriasis Foundation